疟疾诊断市场 - 按产品、技术、最终用途 - 全球预测

由于疟疾盛行率不断上升，特别是在撒哈拉以南非洲、东南亚和拉丁美洲部分地区，预计从 2024 年到 2032 年，疟疾诊断市场规模的复合年增长率将达到 5%。根据世界卫生组织估计，到 2022 年，全球将有 2.49 亿例疟疾病例和 608,000 例与疟疾相关的死亡。有效诊断工具的需求源自于及时识别和治疗疟疾病例以预防严重併发症和降低死亡率的必要性。随着医疗保健基础设施的改善，诊断技术变得更加容易取得。

快速诊断测试 RDT 等创新无需专用设备或电力即可提供快速、准确的结果，彻底改变了资源有限环境中的疟疾诊断。聚合酶炼式反应 PCR 和环介导等温扩增 LAMP 等分子诊断方法的发展也为检测疟疾寄生虫提供了更高的灵敏度和特异性，进一步推动了市场成长。

疟疾诊断产业分为产品、技术、最终用途和地区。

根据产品，仪器领域的市场价值预计将在 2024 年至 2032 年期间出现显着的复合年增长率，这得益于对提供先进和自动化解决方案以提高疟疾检测效率和准确性的强烈需求。自动显微镜系统、核酸扩增分析仪和高通量筛选平台等仪器可简化诊断过程，同时缩短週转时间并提高实验室和医疗机构的通量。

由于显微镜技术领域作为检测疟原虫的可靠且广泛使用的方法的既定作用，到 2032 年，其疟疾诊断市场将显着增长。血液抹片显微镜检查仍然是疟疾诊断的基石，因为它具有高度特异性并且能够识别不同种类的疟原虫寄生虫。显微镜技术的快速进步，例如数位显微镜和自动影像分析系统，以提高疟疾诊断的准确性和效率，也将推动该领域的成长。

亚太地区疟疾诊断产业将在 2024 年至 2032 年期间呈现令人印象深刻的成长。旨在消除和控制疟疾的政府措施和国际资金的增加将大大增加对准确和快速诊断方法的需求。此外，整个地区医疗保健基础设施的扩展和实验室能力的提高正在促进更好地获得先进的诊断技术。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 疟疾盛行率增加
    • 诊断技术的进步
    • 提高预防疟疾的意识和教育
    • 发展中国家越来越多地采用即时检测
  • 产业陷阱与挑战
    • 严格的监管场景
• 成长潜力分析
• 技术景观
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

• 主要趋势
• 仪器
• 试剂盒和试剂

第 6 章：市场估计与预测：按技术分类，2021 - 2032 年

• 主要趋势
• 显微镜检查
• 快速诊断测试
• 分子诊断测试
  • 常规PCR
  • 实时定量PCR
• 其他技术

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 诊所
• 医院
• 诊断中心
• 其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Abbott Laboratories
• Access Bio
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Danaher corporation
• F. Hoffmann-La Roche Ltd.
• Nikon Corporation
• Premier Medical Corporation Private Limited
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

Malaria diagnostics market size is projected to witness 5% CAGR from 2024 - 2032, driven by the increasing prevalence of malaria, particularly in sub-Saharan Africa, Southeast Asia, and parts of Latin America. As per WHO, in 2022, it is estimated that there were 249 million malaria cases and 608,000 malaria-related deaths worldwide. The demand for effective diagnostic tools stems from the necessity to promptly identify and treat malaria cases to prevent severe complications and reduce mortality rates. With the improving healthcare infrastructures, diagnostic technologies have become more accessible.

Innovations, such as rapid diagnostic tests RDTs, which provide quick and accurate results without the need for specialized equipment or electricity, have revolutionized malaria diagnosis in resource-limited settings. The development of molecular diagnostic methods, such as polymerase chain reaction PCR and loop-mediated isothermal amplification LAMP are also offering higher sensitivity and specificity in detecting malaria parasites, further driving the market growth.

The malaria diagnostics industry is classified into product, technology, end-use and region.

Based on product, the market value from the instrument segment is anticipated to observe a significant CAGR during 2024-2032 favored by the strong need for providing advanced and automated solutions that enhance the efficiency and accuracy of malaria testing. Instruments, such as automated microscopy systems, nucleic acid amplification analyzers, and high-throughput screening platforms streamline the diagnostic process while reducing turnaround times and improving throughput in laboratories and healthcare settings.

Malaria diagnostics market from the microscopy technology segment is set to witness notable growth through 2032 due to its established role as a reliable and widely used method for detecting malaria parasites. Microscopic examination of blood smears remains a cornerstone in malaria diagnosis for offering high specificity and the ability to identify different species of Plasmodium parasites. Rapid advancements in microscopy techniques, such as digital microscopy and automated image analysis systems to enhance the accuracy and efficiency of malaria diagnosis will also drive the segment growth.

Asia Pacific malaria diagnostics industry will showcase impressive growth over 2024-2032. Increased government initiatives and international funding aimed at malaria elimination and control programs will significantly boost the demand for accurate and rapid diagnostic methods. Additionally, the expansion of healthcare infrastructure and improvements in laboratory capabilities across the region are facilitating better access to advanced diagnostic technologies.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of malaria
    • 3.2.1.2 Advancement in diagnostic technologies
    • 3.2.1.3 Rising awareness and education regarding malaria prevention
    • 3.2.1.4 Increasing adoption of point-of-care testing in developing countries
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory scenario
• 3.3 Growth potential analysis
• 3.4 Technological landscape
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Instruments
• 5.3 Kits & reagents

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Microscopy
• 6.3 Rapid diagnostic tests
• 6.4 Molecular diagnostic tests
  • 6.4.1 Conventional PCR
  • 6.4.2 Real-time PCR
• 6.5 Other technologies

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Clinics
• 7.3 Hospitals
• 7.4 Diagnostic centers
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Access Bio
• 9.3 Becton, Dickinson and Company
• 9.4 Bio-Rad Laboratories, Inc.
• 9.5 Danaher corporation
• 9.6 F. Hoffmann-La Roche Ltd.
• 9.7 Nikon Corporation
• 9.8 Premier Medical Corporation Private Limited
• 9.9 Siemens Healthineers AG
• 9.10 Thermo Fisher Scientific Inc.